Catalyst Wire Dossier Catalyst Wire Dossier

Candesartan (Atacand)

candesartan · AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Candesartan (Atacand), covering 2014-03-14 to 2014-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers [Phase 4]

See pricing